US2012171664A1PendingUtilityA1
Methods and devices for detection of the strain of a pathogen
Est. expiryOct 28, 2025(expired)· nominal 20-yr term from priority
C07K 16/108G01N 33/569G01N 2333/11
45
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Provided are methods and devices for determining the strain of a pathogen in a sample.
Claims
exact text as granted — not AI-modified1 . A method, comprising
a) contacting a sample comprising a pathogen with a first antibody specific for a variant-specific portion of the pathogen, wherein a pathogen-first antibody complex is formed if the variant-specific portion is present on the pathogen in the sample; b) removing the pathogen-first antibody complexes from said sample, if present; c) contacting the sample with a second antibody specific for a non-variant-specific portion of the pathogen, wherein a pathogen-second antibody complex is formed if the pathogen is still present in the sample; and d) detecting the presence or absence of the second pathogen-antibody complexes; wherein the absence of said second pathogen-antibody complex indicates that the pathogen is of the variant for which the first antibody is specific.
2 . The method of claim 1 , wherein the pathogen is influenza type A.
3 . The method of claim 2 , wherein the first antibody is selected from the group consisting of: an anti-H3 antibody and an anti-H5 antibody.
4 . A device, comprising:
a carrier defining a flow path extending at least from a sample receiving zone to a detection zone, immobilized first antibodies specific for a variant-specific portion of a pathogen of interest disposed along the flow path, immobilized second antibodies specific for a non-variant-specific portion of the pathogen of interest; and wherein: a liquid sample comprising a pathogen received by the receiving zone migrates along the flow path on which the first antibodies are immobilized, and if the pathogen is of the variant for which the first antibodies are specific, the first antibodies capture the pathogen along the flow path and remove it from the sample prior to it reaching the detection zone.
5 . The method of claim 4 , wherein the pathogen is influenza type A.
6 . The method of claim 5 , wherein the first antibody is selected from the group consisting of: an anti-H3 antibody and an anti-H5 antibody.
7 . The method of claim 6 , wherein the second antibody is anti-H1 antibody.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.